WHO ICTRP trial
The effect of Linezolid sequential therapy in children drug resistance and…
ChiCTR2100042287 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100042287 |
|---|---|
| Public title | The effect of Linezolid sequential therapy in children drug resistance and severe tuberculosis |
| Scientific title | The effect of Linezolid sequential therapy in children drug resistance and severe tuberculosis |
| Primary sponsor | Children's Hospital of Chongqing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Tuberculosis |
| Interventions | durg-resistance group:LZD 10mg/kg twice daily for 3m or relieve of symptoms, followed by 10mg/kg once daily to the end of treatmetn;severe tuberculosis group:LZD 10mg/kg twice daily for 1-2m or relieve of symptoms, followed by 10mg/kg once… |
| Registration date | Jan 17, 2021 |
| Target size | durg-resistance group:27;severe tuberculosis group:46 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: